close 76% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 76% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Dashboard

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

Strona główna・Stock List・Emergent BioSolutions Inc
Search

Emergent BioSolutions Inc

Closed

SectorHealthcare

6.26 -5.15

Buy

Price update 13 cze 2025, 19:58 UTC

BuySell

Overview

Share price change

24h

Current

Min

6.18

Max

6.4

Key metrics

By Trading Economics

Income

99M

68M

Sales

33M

222M

EPS

0.71

Profit margin

30.603

Employees

900

EBITDA

120M

133M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+116% upside

Dividends

By Dow Jones

Next Earnings

5 sie 2025

Market Stats

By TradingEconomics

Market Cap

43M

360M

Previous open

11.41

Previous close

6.26

News Sentiment

By Acuity

50%

50%

177 / 380 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

4.95 / N/A Support & Resistance

Emergent BioSolutions Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 cze 2025, 22:33 UTC

Acquisitions, Mergers, Takeovers

Millicom to Acquire Telefonica Ecuador for $380 Million

DJ

Read

13 cze 2025, 23:50 UTC

Acquisitions, Mergers, Takeovers

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- 2nd Update

DJ

Read

13 cze 2025, 23:20 UTC

Acquisitions, Mergers, Takeovers

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- Update

DJ

Read

13 cze 2025, 23:09 UTC

Acquisitions, Mergers, Takeovers

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- WSJ

DJ

Read

13 cze 2025, 23:03 UTC

Acquisitions, Mergers, Takeovers

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal --WSJ

DJ

Read

13 cze 2025, 22:18 UTC

Acquisitions, Mergers, Takeovers

Millicom to Acquire Telefonica Ecuador for $380M

DJ

Read

13 cze 2025, 22:04 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Better Data Facilitate Investments In Oil Patch -- Market Talk

DJ

Read

13 cze 2025, 21:42 UTC

Acquisitions, Mergers, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

DJ

Read

13 cze 2025, 21:35 UTC

Acquisitions, Mergers, Takeovers

Bunge: Outside Date Extended to July 3

DJ

Read

13 cze 2025, 21:35 UTC

Acquisitions, Mergers, Takeovers

Bunge: Subject to Satisfaction of Remaining Conditions, Bunge and Sellers Expect to Complete Transaction July 2

DJ

Read

13 cze 2025, 21:34 UTC

Acquisitions, Mergers, Takeovers

Bunge Gets Mexico Approval for Viterra Deal

DJ

Read

13 cze 2025, 21:32 UTC

Acquisitions, Mergers, Takeovers

Bunge Gets China Approval for Viterra Deal

DJ

Read

13 cze 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

13 cze 2025, 20:45 UTC

Acquisitions, Mergers, Takeovers

23andMe: TTAM Makes Binding Commitments for Additional Consumer Protections and Privacy Safeguards

DJ

Read

13 cze 2025, 20:34 UTC

Acquisitions, Mergers, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- Update

DJ

Read

13 cze 2025, 20:14 UTC

Acquisitions, Mergers, Takeovers

Nonprofit Controlled By 23andMe Co-Founder Anne Wojcicki Would Buy the DNA-Testing Company for $305 Million -- WSJ

DJ

Read

13 cze 2025, 20:14 UTC

Acquisitions, Mergers, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- WSJ

DJ

Read

13 cze 2025, 20:14 UTC

Acquisitions, Mergers, Takeovers

Regeneron Walks Away From 23andMe Acquisition After Wojcicki's Higher Bid -- WSJ

DJ

Read

13 cze 2025, 19:30 UTC

Market Talk

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

DJ

Read

13 cze 2025, 19:12 UTC

Market Talk

Oil Futures Jump As Israel Strikes Iranian Targets -- Market Talk

DJ

Read

13 cze 2025, 19:04 UTC

Market Talk

Canada Military Spending Hike to Lift Long-Term Yields -- Market Talk

DJ

Read

13 cze 2025, 18:54 UTC

Market Talk

Correction to Gold Settles Market Talk

DJ

Read

13 cze 2025, 18:01 UTC

Market Talk

Gold Settles at Record High -- Market Talk

DJ

Read

13 cze 2025, 17:40 UTC

Market Talk

U.S. Oil Rig Count Falls By 3 to 439 -- Market Talk

DJ

Read

13 cze 2025, 17:21 UTC

Market Talk

Dollar Index, Commodities Rise -- Market Talk

DJ

Read

13 cze 2025, 17:02 UTC

Acquisitions, Mergers, Takeovers

Advent Proposal Values Spectris at GBP37.63 Per Share, Company Said Monday -- WSJ

DJ

Read

13 cze 2025, 17:02 UTC

Acquisitions, Mergers, Takeovers

KKR Is Preparing a Bid for High-Tech Instrument Maker Spectris, Sources Say -- WSJ

DJ

Read

13 cze 2025, 17:02 UTC

Acquisitions, Mergers, Takeovers

Private-Equity Firm Is Vying With Advent for the U.K. Company, Sources Say -- WSJ

DJ

Read

13 cze 2025, 17:02 UTC

Acquisitions, Mergers, Takeovers

KKR Making Competing Bid for Equipment Maker Spectris -- WSJ

DJ

Read

13 cze 2025, 16:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

Peer Comparison

Price change

Emergent BioSolutions Inc Forecast

Price Target

By TipRanks

116% upside

12 Months Forecast

Average 13.5 USD  116%

High 15 USD

Low 12 USD

Based on 2 Wall Street analysts offering 12 month price targets forEmergent BioSolutions Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Based on 2 analysts giving stock ratings to Emergent BioSolutions Inc - Dist in the past 3 months.

Technical Score

By Trading Central

4.95 / N/ASupport & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Weak Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

Weak Bearish Evidence

Bearish events outweigh bullish events.

Sentiment

By Acuity

177 / 380 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

818.58

↑ +0.92%

JNJ

Johnson and Johnson

156.9

↑ +0.22%

ABBV

AbbVie Inc

190.58

↓-0.85%

NVO

Novo Nordisk A-S

79.74

↓-1.64%

UNH

UnitedHealth Group Inc

313.25

↓-1.52%